Device applicants warned over fast-approaching Malaysian deadline
This article was originally published in SRA
The final submission deadline for medical device companies wishing to keep their products on the Malaysian market as the country transitions to a conformity assessment-based system is approaching fast1.
You may also be interested in...
COVID-19 has forced a rethink in how care should be delivered. Healthcomms Consulting partner Dan Jones says it is an opportunity that must not be squandered.
Certain Cumberlege Review recommendations are making their way into draft UK legislation as the government presses ahead in shaping the UK’s post-Brexit devices regulatory system.
Delivering innovation is still the driving force for medtechs intent on growing in the market, regardless of COVID-19, the disruptive effects of which have intensified with the appearance of new variants, says Jefferies Healthcare equity analyst Raj Denhoy.